Pharmaceutical
Home » Prostate Cancer Treatment Market

Prostate Cancer Treatment Market

Prostate Cancer Treatment Market By Treatment (Biological Therapy, Chemotherapy ) – Growth, Future Prospects And Competitive Analysis 2017 – 2025
Report Book

Published Date: April 2017
Category: Pharmaceuticals
Report ID:58402
Report Format: PDF
No of Pages: 120

Rating: Credence Reports

Market Insights

This report on the global prostate cancer treatment market examines various drugs used to treat prostate cancer, as well as a pipeline analysis of potential new drugs. According to the National Cancer Institute, approximately 12.9% of men will be diagnosed with prostate cancer at some point during their lifetime. Prostate cancer can be diagnosed before the symptoms start by testing the prostate-specific antigen (PSA) in a man’s blood or through the digital rectal exam (DRE). Currently, there are a handful of players that are leading the prostate cancer treatment market, but in the future, the competition will be more intense as several blockbuster prostate cancer therapeutic drugs are slated to go off-patent.

For the purpose of this study, the various treatment types studied include biological therapy, which includes drugs like Enzalutamide (Xtandi), Abiraterone (Zytiga), and chemotherapy drugs like Docetaxel (Taxotere), and Cabazitaxel (Jevtana). Market size estimates and forecasts for these segments for the period 2015 to 2025 are provided in terms of US$ Mn, along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The pipeline analysis for the prostate cancer treatment market includes estimated market sales of Phase III drugs through 2025. We have estimated sales of very specific molecules based on the type (biological or chemical), sponsor, depicted peak sales by leading market experts, and other factors. A few prominent phase III drugs are ProstVac, Tasquinimod Active, ARN-509, ODM-201, and Yervoy, etc.

The geographic segmentation of the global prostate cancer treatment market is performed for the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The regions are also further sub-segmented on the basis of major countries. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

The American Cancer Society (ACS) estimates that more than 12 million new cases of cancer are diagnosed worldwide each year. Around 99% of the cases of prostate cancer are most commonly seen after the age of 50ncer are diagnosed worldwide each year. Around 99% of the cases of prostate cancer are most commonly seen after the age of 50. Based on the treatment type, the prostate cancer treatment market is segmented into:

Biological therapy

  • Enzalutamide
  • Abiraterone
  • Leuprolide
  • Goserelin
  • Triptorelin
  • Histrelin
  • Degarelix
  • Sipuleucel-T

Chemotherapy

  • Mitotic inhibitors, e.g., Docetaxel, Cabazitaxel
  • Topoisomerase inhibitors, e.g., mitoxantrone
  • alkylating antineoplastic agent, e.g., estramustine

According to market experts, biological therapy is the first line of treatment in order to reduce androgens in the body (testosterone and dihydrotestosterone) as they stimulate the growth of prostate cancer cells. However, the drug-related side effects are high, so patients are opting for chemotherapy, where drugs such as docetaxel, cabazitaxel, mitoxantrone, and estramustine are prescribed for the treatment of prostate cancer. Chemotherapy is a treatment of choice for patients who have become resistant to biological therapy and whose prostate cancer has spread outside the prostate gland and metastasized in distant organs. Biological therapy had the largest market share in the treatment in 2016, followed by chemotherapy. Targeted biological therapy is expected to grow significantly between 2017 and 2025, owing to a promising pipeline. Improved reimbursement policies, which have increased treatment expenditure in developed markets; an aging population coupled with growing public awareness; and technological advancements in drug development with promising pipeline products for the treatment of prostate cancer were the key factors assisting segment growth.

Or, for the purpose of this study, the global prostate cancer treatment market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

In 2016, North America was identified as the largest market for prostate cancer treatment. According to the American Cancer Society, in 2017, there will be about 161,360 new cases of prostate cancer, attributed mainly to an aging population and high public awareness of the disease, which has led to early diagnosis and treatment for prostate cancer. Cancer Research UK states that prostate cancer accounts for 26% of all new cases of cancer in males. Europe is expected to be the second-largest market due to rising public awareness related to early disease diagnosis, improved healthcare infrastructure, government and non-government organizations arranging awareness activities and camps, and supportive reimbursement policies. Newly approved drug molecules for the treatment of pancreatic cancer have a good acceptance and penetration rate in the European market. The growth of the Asia Pacific prostate cancer treatment market is attributed to factors like the rising prevalence of the disease, increasing investments in R&D, and higher disposable income in these regions. However, factors such as developing health infrastructure, increasing awareness among people about health care, and an aging population are going to fuel the rapid growth of the prostate cancer treatment market in Latin America, the Middle East, and Africa in the near future.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Prostate Cancer Treatment Market Portraiture
2.2 Global Prostate Cancer Treatment Market, by Type of Treatment, 2016 (US$ Mn)
2.3 Global Prostate Cancer Treatment Market Share, by Geography, 2016 (Value %)

Chapter 3 Prostate Cancer Treatment Market Analysis
3.1 Global Prostate Cancer Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Growing Prevalence of Prostate Cancer
3.2.1.2 Rise in aging population and public awareness of Prostate cancer
3.2.2 Challenges
3.2.2.1 Ambiguous Reimbursement Policies causing decrease in healthcare expenditure
3.2.3 Opportunities
3.2.3.1 Developing R&D technology leading to more target specific drugs and strong emerging pipeline
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Prostate Cancer Treatment Market

Chapter 4 Global Prostate Cancer Treatment Market Analysis, by Treatment
4.1 Introduction
4.2 Biological Therapy
4.2.1 Enzalutamid
4.2.2 Abiraterone
4.2.3 Leuprolide
4.2.4 Goserelin
4.2.5 Triptorelin
4.2.6 Histrelin
4.2.7 Degarelix
4.2.8 Sipuleucel-T
4.3 Chemotherapy
4.3.1 Mitotic inhibitors e.g. Docetaxel, Cabazitaxel
4.3.2 Topoisomerase inhibitors e.g. Mitoxantrone
4.3.3 Alkylating antineoplastic agent e.g. Estramustine

Chapter 5 Global Prostate Cancer Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America (Brazil, Mexico and Rest of Latin America)
5.6 Middle East and Africa (United Arab Emirates, Saudi Arabia and Rest of Middle East and Africa)

Chapter 6 Company Profiles
6.1 Tolmar Inc.
6.2 Astellas Pharma, Inc.
6.3 AstraZeneca Plc
6.4 Ferring Pharmaceuticals
6.5 Johnson & Johnson
6.6 Abbott Laboratories
6.7 Sanofi
6.8 Ipsen
6.9 Novartis
6.10 Bayer Healthcare Pharmaceuticals, Inc

List of Figures

FIG. 1 Prostate Cancer Treatment Market: Research Methodology
FIG. 2 Global Prostate Cancer Treatment Market, by Type of Treatment, 2016 (US$ Mn)
FIG. 3 Global Prostate Cancer Treatment Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Prostate Cancer Treatment Market, by Geography
FIG. 5 Enzalutamid Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 6 Abiraterone Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 7 Leuprolide Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 8 Goserelin Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Triptorelin Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Histrelin Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Degarelix Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Sipuleucel-T Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 13 Mitotic inhibitors Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 14 Topoisomerase inhibitors Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 15 Alkylating antineoplastic agent Market for Prostate Cancer treatment, 2015 – 2025 (US$ Mn)
FIG. 16 North America Prostate Cancer Treatment Market,2015 – 2025 (US$ Mn)
FIG. 17 Europe Prostate Cancer Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 18 Asia Pacific Prostate Cancer Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 19 Latin America Prostate Cancer Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 20 Middle East and Africa Prostate Cancer Treatment Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Prostate Cancer Treatment Market
TABLE 2 Global Prostate Cancer Treatment Market, by Treatment, 2015 – 2025 (US$ Mn)
TABLE 3 Global Prostate Cancer Treatment Market, Biological Therapy, 2015 – 2025 (US$ Mn)
TABLE 4 Global Prostate Cancer Treatment Market, Chemotherapy, 2015 – 2025 (US$ Mn)
TABLE 5 Global Prostate Cancer Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 6 Tolmar Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 7 Astellas Pharma, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 8 AstraZeneca Plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 9 Ferring Pharmaceuticals : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Johnson & Johnson : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 Abbott Laboratories : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 Sanofi : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Ipsen : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Novartis : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Bayer Healthcare Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

Frequently Asked Questions

What is the size of Prostate Cancer Treatment Market?

The market for Prostate Cancer Treatment Market is expected to reach US$ 18.4 Bn in 2025.

What is the Prostate Cancer Treatment Market CAGR?

The Prostate Cancer Treatment Market is expected to see significant CAGR growth over the coming years, at 12.3%

What is the Forecast period considered for Prostate Cancer Treatment Market?

The report is forecasted to 2017-2025.

What is the base year considered for Prostate Cancer Treatment Market?

The base year of this report is 2016.

Who are the major players in this Market?

Tolmar Inc., Astellas Pharma, Inc.,AstraZeneca Plc,Ferring Pharmaceuticals,Johnson & Johnson are some of the major players in the global market.

Healthcare

Trientine Hydrochloride Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 58081
Report Format: PDF
No of Pages: 247

Pharmaceutical

Pharmaceutical Chemicals Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62118
Report Format: PDF
No of Pages: 247

Pharmaceutical

Wilson’s Disease Drugs Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 58947
Report Format: PDF
No of Pages: 190

Healthcare

Stretch Marks Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62116
Report Format: PDF
No of Pages: 221

Pharmaceutical

Fetal Bovine Serum Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62115
Report Format: PDF
No of Pages: 238

Healthcare

Cirrhosis Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62114
Report Format: PDF
No of Pages: 229

Pharmaceutical

Congenital Hyperinsulinism Treatment Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62113
Report Format: PDF
No of Pages: 219

Healthcare

Cryptococcal Meningitis Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62112
Report Format: PDF
No of Pages: 237

Healthcare

Dermatology Endoscopy devices Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62111
Report Format: PDF
No of Pages: 237

Healthcare

Cementless Total Knee Arthroplasty Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62110
Report Format: PDF
No of Pages: 228

Healthcare

Cell & Gene Therapy Clinical Trials Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62109
Report Format: PDF
No of Pages: 228

HealthCare

Self-sampling Blood Collection and Storage Device Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61352
Report Format: PDF
No of Pages: 234

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now